Saturday - April 19, 2025
Blackstone Life Sciences and Anthos Therapeutics Announce Novartis Has Completed the Acquisition of Anthos Therapeutics in a Deal Valued at Up to $3.1B, With $925M Paid Upfront
April 04, 2025
NEW YORK, April 4 -- Blackstone, an investment firm, issued the following news release:

* * *

Blackstone Life Sciences and Anthos Therapeutics Announce Novartis has Completed the Acquisition of Anthos Therapeutics in a Deal Valued at up to $3.1B, with $925M Paid Upfront

The deal affirms Blackstone's vision of building companies around innovative products to meet unmet patient needs

CAMBRIDGE, Mass., April 03, 2025 - Blackstone Life Science . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products